DCL: Explanation of changes in profit after tax in Quarter 2.2026
Filed with HOSE · · 2 pages · English
Cuu Long Pharmaceutical JSC on 6ix
Story so far
Earlier from Cuu Long Pharmaceutical JSC
- DCL: Report on Corporate Governance for the first six months of 2026
- DCL: Approval of the selection of an auditing firm for the 2026 financial statements
- DCL: Approval of the adjustment of the investment project of pharmaceutical manufacturing plant
- DCL: Approval of contracts between the company and related parties
- DCL: Update Charter
Later from Cuu Long Pharmaceutical JSC
- DCL: Explanation of changes in profit after tax for the first haft of 2026
- DCL: Change in personnel
- DCL: Approval of the additional capital contribution to the subsidiary
Follow Cuu Long Pharmaceutical JSC into a list and get an email when it puts out news.
Follow Cuu Long Pharmaceutical JSC